• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine
  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Pharma & Human Health

Pharma & Human Health

SkinBiotix® Shows Efficacy in First Human Study

April 8, 2019 Microbiome Times

SkinBioTherapeutics plc (AIM: SBTX – “SkinBioTherapeutics” or the “Company”), a life science company focused on skin health, provides the results of its first human study. The study was primarily undertaken to show the effects of […]

Editor's Choice

Interview With Aoife Brennan, CEO, Synlogic Inc

April 7, 2019 Kristina Campbell

Kristina Campbell talks to Aoife Brennan to find out how Synlogic is pioneering the development of engineered probiotics to deliver specific functions in the human body to compliment for deficiencies brought about by disease.

Pharma & Human Health

C3J Therapeutics Announces Issuance of U.S. Patent Covering Synthetic Bacteriophage

April 3, 2019 Microbiome Times

C3J Therapeutics, Inc. (C3J) a private clinical stage biotechnology company focused on the development of novel targeted antimicrobials based on bacteriophage, announced that the United States Patent and Trademark Office (USPTO) has issued patent No. […]

Editor's Choice

The Human Microbiome: A Diversity of Players Ranging from Academics to Dedicated Platforms

April 3, 2019 Biofortis Mérieux NutriSciences and Cepton Strategies

Following Biofortis first paper The human microbiome: a global overview of clinical trials activity, this article compares the emergence of the human microbiome field with the rise of human genomics through a review on how […]

Finance

Lonza and Chr. Hansen in Joint Venture to Accelerate Momentum in Microbiome

April 2, 2019 Microbiome Times

Danish bioscience company, Chr. Hansen, joins forces with Lonza AG to pioneer the emerging market for live biotherapeutic products Chr. Hansen Holding A/S, a leading global bioscience company, and Lonza AG, a leading pharma contract […]

Finance

Holobiome Announces Second Collaboration with Johnson & Johnson Innovation

April 2, 2019 Microbiome Times

Holobiome, a biotechnology company developing microbiome therapeutics that target the gut-brain-axis, announces a research collaboration with Johnson & Johnson Consumer Inc. focused on developing proprietary bacterial consortia to treat digestive disorders. Johnson & Johnson Innovation […]

Pharma & Human Health

New Randomized Double-Blind Placebo-Controlled Trial Finds Probiotics to Benefit Mood and Quality of Sleep in Healthy Students

April 1, 2019 Nina Vinot

A collaboration between the University of Verona, Microbion and Biolab Research recently led to the publication in Frontiers of Psychiatry of new data on the potential of specific probiotics to support mental wellbeing. The bidirectional […]

Finance

Micreos Raises €30 Million for Endolysin Technology Set to Replace Antibiotics

April 1, 2019 Microbiome Times

Dutch biotechnology company Micreos announced it has secured €30 million in funding to accelerate the development of its endolysin technology, set to replace antibiotics. Proceeds are earmarked for the clinical development program of its endolysin […]

Editor's Choice

5-Minute Microbiome Science Roundup: March 2019

April 1, 2019 Kristina Campbell

March saw the publication of many excellent scientific publications related to different aspects of the microbiome. Here’s a 5-minute roundup of 5 recent papers worth knowing about. A Weaning Reaction to Microbiota Is Required for […]

Pharma & Human Health

Viome and Helomics Partner to Identify Personalized Treatment for Ovarian Cancer Patients

March 27, 2019 Microbiome Times

Viome, a company transforming health through personalized nutrition based on individual biology, announced it will collaborate with precision health leader, Helomics, to study the link between the gut microbiome and ovarian cancer. The teams will […]

Pharma & Human Health

New Study Identifies Potential Treatment For Higher Rate Of Preterm Birth Among African American Women

March 27, 2019 Microbiome Times

It may be possible to lower the high risk of preterm birth among African American women with certain immune and bacterial factors in the microbiome of the cervix and vagina that appear to modulate this […]

Posts navigation

« 1 … 63 64 65 … 85 »

Sign Up to Free Newsletter

Editor’s Choice

  • Siolta Therapeutics Reports Positive Phase 2 Results from the ADORED Study
    November 17, 2025
  • The OMNIgene™•VAGINAL device – Optimized solutions for vaginal microbiome studies
    November 12, 2025
  • MRM Health Raises €55 Million Series B to Advance Microbiome-Based Biotherapeutic Product Pipeline
    September 4, 2025
  • Targeting the ileo-colonic region: Innovative solutions for sensitive APIs
    August 21, 2025
  • EXPERT’Biome CDMO by Lallemand at Microbiome Times Forum
    June 23, 2025
sign up

Sign up to the Microbiome Times newsletter